These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18428571)

  • 1. Preclinical models to evaluate potential pharmacotherapeutic agents in treating alcoholism and studying the neuropharmacological bases of ethanol-seeking behaviors in rats.
    June HL
    Curr Protoc Neurosci; 2002 Aug; Chapter 9():Unit 9.12. PubMed ID: 18428571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of naltrexone on oral consumption of concurrently available ethanol and cocaine in the rat.
    Stromberg MF; Sengpiel T; Mackler SA; Volpicelli JR; O'Brien CP; Vogel WH
    Alcohol; 2002 Nov; 28(3):169-79. PubMed ID: 12551758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of naltrexone and nalmefene on subjective response to alcohol among non-treatment-seeking alcoholics and social drinkers.
    Drobes DJ; Anton RF; Thomas SE; Voronin K
    Alcohol Clin Exp Res; 2004 Sep; 28(9):1362-70. PubMed ID: 15365307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Environmental cues, alcohol seeking, and consumption in baboons: effects of response requirement and duration of alcohol abstinence.
    Weerts EM; Goodwin AK; Kaminski BJ; Hienz RD
    Alcohol Clin Exp Res; 2006 Dec; 30(12):2026-36. PubMed ID: 17117968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of naltrexone alone and in combination with acamprosate on the alcohol deprivation effect in rats.
    Heyser CJ; Moc K; Koob GF
    Neuropsychopharmacology; 2003 Aug; 28(8):1463-71. PubMed ID: 12700689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mosaic of addiction.
    O'Brien CP
    Am J Psychiatry; 2004 Oct; 161(10):1741-2. PubMed ID: 15465965
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of alcohol availability, access to alcohol, and naltrexone on self-reported craving and patterns of drinking in response to an alcohol-cue availability procedure.
    Kruse MI; Radnovich AJ; Kalapatapu RK; Mehdiyoun N; Chambers RA; Davidson D
    J Stud Alcohol Drugs; 2012 Mar; 73(2):205-15. PubMed ID: 22333328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Family history of alcoholism influences naltrexone-induced reduction in alcohol drinking.
    Krishnan-Sarin S; Krystal JH; Shi J; Pittman B; O'Malley SS
    Biol Psychiatry; 2007 Sep; 62(6):694-7. PubMed ID: 17336941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rat animal models for screening medications to treat alcohol use disorders.
    Bell RL; Hauser SR; Liang T; Sari Y; Maldonado-Devincci A; Rodd ZA
    Neuropharmacology; 2017 Aug; 122():201-243. PubMed ID: 28215999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral ethanol self-administration in rats: models of alcohol-seeking behavior.
    Samson HH; Pfeffer AO; Tolliver GA
    Alcohol Clin Exp Res; 1988 Oct; 12(5):591-8. PubMed ID: 3067600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Building bridges: the transdisciplinary study of craving from the animal laboratory to the lamppost.
    Monti PM; Tidey J; Czachowski CL; Grant KA; Rohsenow DJ; Sayette M; Maners N; Pierre P
    Alcohol Clin Exp Res; 2004 Feb; 28(2):279-87. PubMed ID: 15112935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of PPARγ by pioglitazone potentiates the effects of naltrexone on alcohol drinking and relapse in msP rats.
    Stopponi S; de Guglielmo G; Somaini L; Cippitelli A; Cannella N; Kallupi M; Ubaldi M; Heilig M; Demopulos G; Gaitanaris G; Ciccocioppo R
    Alcohol Clin Exp Res; 2013 Aug; 37(8):1351-60. PubMed ID: 23550625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic approaches to the management of alcoholism.
    Anton RF
    J Clin Psychiatry; 2001; 62 Suppl 20():11-7. PubMed ID: 11584870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical and clinical studies on naltrexone: what have they taught each other?
    Froehlich J; O'Malley S; Hyytiä P; Davidson D; Farren C
    Alcohol Clin Exp Res; 2003 Mar; 27(3):533-9. PubMed ID: 12658121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic dissociation between impulsivity and alcohol drinking in high alcohol preferring mice.
    Oberlin BG; Bristow RE; Heighton ME; Grahame NJ
    Alcohol Clin Exp Res; 2010 Aug; 34(8):1363-75. PubMed ID: 20491739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of motivational changes on drinking outcomes in pharmacobehavioral treatment for alcohol dependence.
    Penberthy JK; Hook JN; Vaughan MD; Davis DE; Wagley JN; Diclemente CC; Johnson BA
    Alcohol Clin Exp Res; 2011 Sep; 35(9):1694-704. PubMed ID: 21676008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of L-cysteine on reinstatement of ethanol-seeking behavior and on reinstatement-elicited extracellular signal-regulated kinase phosphorylation in the rat nucleus accumbens shell.
    Peana AT; Giugliano V; Rosas M; Sabariego M; Acquas E
    Alcohol Clin Exp Res; 2013 Jan; 37 Suppl 1():E329-37. PubMed ID: 22823513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of accelerated development of stable alcoholic motivation in rats for studying potential alcohol deterrents].
    Salimov RM; Viglinskaia IV
    Biull Eksp Biol Med; 1990 Apr; 109(4):364-6. PubMed ID: 2386830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hypocretin/orexin system as a target for excessive motivation in alcohol use disorders.
    Moorman DE
    Psychopharmacology (Berl); 2018 Jun; 235(6):1663-1680. PubMed ID: 29508004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?
    Richardson K; Baillie A; Reid S; Morley K; Teesson M; Sannibale C; Weltman M; Haber P
    Addiction; 2008 Jun; 103(6):953-9. PubMed ID: 18482418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.